| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |